# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Goal to broaden access to cost-effective and innovative laboratory services in OhioSECAUCUS, N.J. and COLUMBUS, Ohio, July 10, ...
Citigroup analyst Patrick Donnelly upgrades Quest Diagnostics (NYSE:DGX) from Neutral to Buy and raises the price target fro...
Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $145 to $...